Homocysteine level and cognitive function in patients with arterial disease: The second manifestations of ARTerial disease study

Journal of the American Geriatrics Society

Volumn 54, Issue 4, 2006, Pages 575-579

  Raamt, Fleur Van A ^a   Kalmijn, Sandra ^a   Mali, Willem P Th M ^a   Van Zandvoort, Martine J E ^b   Van Der Graaf, Yolanda ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cognitive function; Homocysteine; Vascular disease

Indexed keywords

HOMOCYSTEINE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE DISTRIBUTION; AGED; ARTERY DISEASE; ARTICLE; ATTENTION; BLOOD VESSEL INJURY; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGY; RISK FACTOR; SCREENING; STANDARDIZATION; VISION;

ADULT; AGED; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 33645505327     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00653.x     Document Type: Article

References (31)

1. Dufouil C Alperovitch A Ducros V et al. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003 53 214 221.
2. Teunissen CE Blom AH van Boxtel MP et al. Homocysteine A marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003 7 153 159.
3. Mooijaart SP Gussekloo J Frolich M et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age The Leiden 85-Plus study. Am J Clin Nutr 2005 82 866 871.
4. Clarke R Daly L Robinson K et al. Hyperhomocysteinemia An independent risk factor for vascular disease. N Engl J Med 1991 324 1149 1155.
5. Hankey GJ Eikelboom JW. Homocysteine and vascular disease. Lancet 1999 354 407 413.
6. Boushey CJ Beresford SA Omenn GS et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995 274 1049 1057.
7. Perry IJ Refsum H Morris RW et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995 346 1395 1398.
8. Breteler MM Claus JJ Grobbee DE et al. Cardiovascular disease and distribution of cognitive function in elderly people. The Rotterdam Study. BMJ 1994 308 1604 1608.
9. Lipton SA Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994 330 613 622.
10. White AR Huang X Jobling MF et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures Possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem 2001 76 1509 1520.
11. Bisschops RH van der Graaf Y Mali WP et al. Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 2004 174 87 92.
12. Simons PC Algra A van de Laak MF et al. Second Manifestations of ARTerial disease (SMART) study. Rationale and design. Eur J Epidemiol 1999 15 773 781.
13. Giele JL Witkamp TD Mali WP et al. Silent brain infarcts in patients with manifest vascular disease. Stroke 2004 35 742 746.
14. Shipchandler MT Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995 41 991 994.
15. Nelson HE. National Adult Reading Test (NART) Manual. Windsor, UK NFER-Nelson 1982.
16. McGurn B Starr JM Topfer JA et al. Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology 2004 62 1184 1186.
17. Lezak MD. Neuropsychological Assessment 3rd Ed. Oxford Oxford University Press 1995.
18. Burgess PW Shallice T. Bizarre responses, rule detection and frontal lobe lesions. Cortex 1996 32 241 259.
19. Borkowski JG Benton AL Spreen O. Word fluency and brain damage. Neuropsychologia 1967 5 135 140.
20. Wilkins AJ Shallice T McCarthy R. Frontal lesions and sustained attention. Neuropsychologia 1987 25 359 365.
21. Wright CB Lee H-S Paik MC et al. Total homocysteine and cognition in a tri-ethnic cohort. The Northern Manhattan Study. Neurology 2004 63 254 260.
22. Miller JW Green R Ramos MI et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003 78 441 447.
23. Prins ND den Heijer T Hofman A et al. Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 2002 59 1375 1380.
24. Luchsinger JA Tang MX Shea S et al. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004 62 1972 1976.
25. Kalmijn S Launer LJ Lindemans J et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects. The Rotterdam Study. Am J Epidemiol 1999 150 283 289.
26. Riggs KM Spiro A III. Tucker K et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996 63 306 314.
27. McCaddon A Hudson P Davies G et al. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001 12 309 313.
28. Van Zandvoort MJ Kappelle LJ Algra A et al. Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life. J Neurol Neurosurg Psychiatry 1998 65 697 702.
29. Geschwind DH Robidoux J Alarcon M et al. Dementia and neurodevelopmental predisposition Cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol 2001 50 741 746.
30. Ellinson M Thomas J Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004 17 371 383.
31. Bots ML van Swieten JC Breteler MM et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993 341 1232 1237.